REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 18 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $11,000 | +450.0% | 21,186 | +42.1% | 0.00% | – |
| Q4 2016 | $2,000 | -91.3% | 14,906 | -86.6% | 0.00% | -100.0% |
| Q3 2016 | $23,000 | -48.9% | 111,386 | -38.4% | 0.00% | 0.0% |
| Q2 2016 | $45,000 | -15.1% | 180,876 | +13.1% | 0.00% | 0.0% |
| Q1 2016 | $53,000 | +1.9% | 159,977 | +11.8% | 0.00% | 0.0% |
| Q4 2015 | $52,000 | -43.5% | 143,107 | -18.9% | 0.00% | -50.0% |
| Q3 2015 | $92,000 | +8.2% | 176,453 | +26.2% | 0.00% | 0.0% |
| Q2 2015 | $85,000 | +750.0% | 139,787 | +939.3% | 0.00% | – |
| Q1 2015 | $10,000 | -95.9% | 13,450 | -96.1% | 0.00% | -100.0% |
| Q4 2014 | $243,000 | +268.2% | 346,822 | +325.4% | 0.00% | +300.0% |
| Q3 2014 | $66,000 | +247.4% | 81,537 | +276.3% | 0.00% | – |
| Q2 2014 | $19,000 | -94.3% | 21,668 | -92.9% | 0.00% | -100.0% |
| Q1 2014 | $331,000 | +903.0% | 305,764 | +317.8% | 0.00% | – |
| Q3 2013 | $33,000 | – | 73,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $109,000 | 0.05% |
| CONDOR CAPITAL MANAGEMENT | 211,371 | $154,000 | 0.04% |
| Benin Management CORP | 83,000 | $61,000 | 0.03% |
| First Heartland Consultants, Inc. | 20,000 | $15,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $16,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $131,000 | 0.00% |
| Moors & Cabot, Inc. | 11,000 | $7,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 3,000 | $2,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| WFG Advisors, LP | 3,500 | $3,000 | 0.00% |